PMC:7558914 / 23006-23234
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 537 | 136-144 | Species | denotes | patients | Tax:9606 |
| 557 | 112-132 | Disease | denotes | respiratory distress | MESH:D012128 |
| 558 | 150-170 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T40 | 112-132 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T148 | 0-228 | Sentence | denotes | Anakinra, an interleukin 1 receptor antagonist, has also been proposed in order to reduce hyperinflammation and respiratory distress in patients with SARS-CoV-2 infection, but here, too, limited evidence has been published [32]. |